前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201702258907454287
整理番号：17A1719122
Toll様受容体8作動薬ナノ粒子は生BCGワクチンの免疫調節作用を模倣し,新生児先天性および適応免疫応答を増強する【Powered by NICT】
Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
Dowling David J.
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Dowling David J.
(Harvard Medical School, Boston, Mass)
,
Scott Evan A.
(Department of Biomedical Engineering, Northwestern University, Evanston, Ill)
,
Scheid Annette
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Scheid Annette
(Harvard Medical School, Boston, Mass)
,
Scheid Annette
(Division of Newborn Medicine, Floating Hospital for Children, Tufts Medical Center, Boston, Mass)
,
Scheid Annette
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Bergelson Ilana
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Joshi Sweta
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Joshi Sweta
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Pietrasanta Carlo
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Pietrasanta Carlo
(Harvard Medical School, Boston, Mass)
,
Pietrasanta Carlo
(Neonatal Intensive Care Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy)
,
Pietrasanta Carlo
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Brightman Spencer
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Brightman Spencer
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Sanchez-Schmitz Guzman
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Sanchez-Schmitz Guzman
(Harvard Medical School, Boston, Mass)
,
Sanchez-Schmitz Guzman
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Van Haren Simon D.
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Van Haren Simon D.
(Harvard Medical School, Boston, Mass)
,
Van Haren Simon D.
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Ninkovic Jana
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Ninkovic Jana
(Harvard Medical School, Boston, Mass)
,
Kats Dina
(Department of Biomedical Engineering, Northwestern University, Evanston, Ill)
,
Guiducci Cristiana
(Dynavax Technologies, Berkeley, Calif)
,
de Titta Alexandre
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Bonner Daniel K.
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Hirosue Sachiko
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Swartz Melody A.
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Swartz Melody A.
(Institute for Molecular Engineering, University of Chicago, Chicago, Ill)
,
Hubbell Jeffrey A.
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Hubbell Jeffrey A.
(Institute for Molecular Engineering, University of Chicago, Chicago, Ill)
,
Levy Ofer
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Levy Ofer
(Harvard Medical School, Boston, Mass)
,
Levy Ofer
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
資料名：
Journal of Allergy and Clinical Immunology
(Journal of Allergy and Clinical Immunology)
巻： 140 号： 5 ページ： 1339-1350 発行年： 2017年
JST資料番号： A0182B ISSN： 0091-6749 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： オランダ (NLD) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。